Skip to main content
Erschienen in: Journal of General Internal Medicine 3/2019

02.01.2019 | Original Research

The Effect of Financial Conflict of Interest, Disclosure Status, and Relevance on Medical Research from the United States

verfasst von: Deepa V. Cherla, MD, Cristina P. Viso, MD, Julie L. Holihan, MD, MS, Karla Bernardi, MD, Maya L. Moses, MD, Krislynn M. Mueck, MD, Oscar A. Olavarria, MD, Juan R. Flores-Gonzalez, MD, Courtney J. Balentine, MD, Tien C. Ko, MD, Sasha D. Adams, MD, Claudia Pedroza, PhD, Lillian S. Kao, MD, MS, Mike K. Liang, MD

Erschienen in: Journal of General Internal Medicine | Ausgabe 3/2019

Einloggen, um Zugang zu erhalten

Abstract

Background

Financial interactions between industry and healthcare providers are reportable. Substantial discrepancies have been detected between industry and self-report of these conflicts of interest (COIs).

Objective

Our aim was to determine if authors who fail to disclose reportable COI are more likely to publish findings that are favorable to industry than authors with no COI.

Design

In this blinded, observational study of medical and surgical primary research articles in PubMed, 590 articles were reviewed.

Main Measures

Reportable financial relationships between authors and industry were evaluated. COIs were considered to have relevance if they were associated with the product(s) mentioned by an article. Primary outcome was favorability, defined as an impression favorable to the product(s) discussed by an article and determined by 3 independent, blinded clinicians for each article. Primary analysis compared Incomplete Self-Disclosure to No COI. Two-level multivariable mixed-effects ordered logistic regression was used to assess factors associated with favorability.

Key Results

A 69% discordance rate existed between industry and self-report in COI disclosure.
When authors failed to disclose COI, their conclusions were more likely to favor industry partners than authors without COI (favorable ratings 73% versus 62%, RR 1.18, p = < 0.001). On univariate (any COI 74% versus no COI 62%, RR 1.11, p = < 0.001) and multivariable analyses, any COI was associated with favorability.

Conclusions

All financial COIs (disclosed or undisclosed, relevant or not relevant, research or non-research) influence whether studies report findings favorable to industry sponsors.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat C. D. DeAngelis, P. B. Fontanarosa, A. Flanagin, Reporting financial conflicts of interest and relationships between investigators and research sponsors. JAMA.4, 286(1):89–91 (2001 Jul). C. D. DeAngelis, P. B. Fontanarosa, A. Flanagin, Reporting financial conflicts of interest and relationships between investigators and research sponsors. JAMA.4, 286(1):89–91 (2001 Jul).
2.
Zurück zum Zitat R. Steinbrook, Controlling conflict of interest—proposals from the Institute of Medicine. N Engl J Med. 360(21):2160–3 (2009 May 21).CrossRef R. Steinbrook, Controlling conflict of interest—proposals from the Institute of Medicine. N Engl J Med. 360(21):2160–3 (2009 May 21).CrossRef
3.
Zurück zum Zitat O. Olavarria, H. L. Holihan, D. Cherla, C. A. Perez, L. S. Kao, T. C. Ko, M. K. Liang. A comparison of self-reported conflict of interest among published hernia researchers to the Centers of Medicare and Medicaid Services Open Payments Database. J Am Coll Surg. pii: S1072–7515(17)30136–9 (2017 Feb 3). [Epub ahead of print] O. Olavarria, H. L. Holihan, D. Cherla, C. A. Perez, L. S. Kao, T. C. Ko, M. K. Liang. A comparison of self-reported conflict of interest among published hernia researchers to the Centers of Medicare and Medicaid Services Open Payments Database. J Am Coll Surg. pii: S1072–7515(17)30136–9 (2017 Feb 3). [Epub ahead of print]
4.
Zurück zum Zitat B. Lo, M. J. Field, Eds. Institute of Medicine. Conflict of Interest in Medical Research, Education and Practice (The National Academies Press, Washington, DC, 2009). B. Lo, M. J. Field, Eds. Institute of Medicine. Conflict of Interest in Medical Research, Education and Practice (The National Academies Press, Washington, DC, 2009).
5.
Zurück zum Zitat L. A. Bero, Q. Grundy. Why having a (nonfinancial) interest is not a conflict of interest. PLoS Biol. 14(12):e2001221 (2016 Dec 21).CrossRef L. A. Bero, Q. Grundy. Why having a (nonfinancial) interest is not a conflict of interest. PLoS Biol. 14(12):e2001221 (2016 Dec 21).CrossRef
6.
Zurück zum Zitat S. Heres, J. Davis, K. Maino, E. Jetzinger, W. Kissling, S. Leucht. Why olanzapine beats risperidone, respiderone beats quetiapine, and quetiapine beats olanzapine: An exploratory analysis of head-to-head comparison studies of second-generation antipsychotics. Am J Psychiatry. 163(2):185–94 (2006 Feb).CrossRef S. Heres, J. Davis, K. Maino, E. Jetzinger, W. Kissling, S. Leucht. Why olanzapine beats risperidone, respiderone beats quetiapine, and quetiapine beats olanzapine: An exploratory analysis of head-to-head comparison studies of second-generation antipsychotics. Am J Psychiatry. 163(2):185–94 (2006 Feb).CrossRef
7.
Zurück zum Zitat M. E. Flacco, L. Manzoli, S. Boccia, L. Capasso, K. Aleksovska, A. Rosso, G. Scaioli, C. De Vito, R. Siliquini, P. Villari, J. P. Ioannidis. Head-to-head randomized trials are mostly industry sponsored and almost always favor the industry sponsor. J Clin Epidemiol. 68(7):811–20 (2015 Jul).CrossRef M. E. Flacco, L. Manzoli, S. Boccia, L. Capasso, K. Aleksovska, A. Rosso, G. Scaioli, C. De Vito, R. Siliquini, P. Villari, J. P. Ioannidis. Head-to-head randomized trials are mostly industry sponsored and almost always favor the industry sponsor. J Clin Epidemiol. 68(7):811–20 (2015 Jul).CrossRef
9.
Zurück zum Zitat J. B. Hrachovec, M. Mora. Reporting of 6-month vs 12-month data in a clinical trial of celecoxib. JAMA. 286(19):2398; author reply 2399–2400 (2001 Nov 21). J. B. Hrachovec, M. Mora. Reporting of 6-month vs 12-month data in a clinical trial of celecoxib. JAMA. 286(19):2398; author reply 2399–2400 (2001 Nov 21).
10.
Zurück zum Zitat L. J. Hirsch. Conflicts of interest, authorship, and disclosures in industry-related scientific publications: The tort bar and editorial oversight of medical journals. Mayo Clin Proc. 84(9):811–21 (2009 Sep).CrossRef L. J. Hirsch. Conflicts of interest, authorship, and disclosures in industry-related scientific publications: The tort bar and editorial oversight of medical journals. Mayo Clin Proc. 84(9):811–21 (2009 Sep).CrossRef
11.
Zurück zum Zitat P. Doshi. No correction, no retraction, no apology, no comment: Paroxetine trial reanalysis raises questions about institutional responsibility. BMJ. 351:h4629 (2015 Sep 16).CrossRef P. Doshi. No correction, no retraction, no apology, no comment: Paroxetine trial reanalysis raises questions about institutional responsibility. BMJ. 351:h4629 (2015 Sep 16).CrossRef
13.
Zurück zum Zitat B. R. DeGeorge Jr, M. C. Holland, D. B. Drake. The impact of conflict of interact in abdominal wall reconstruction with acellular dermal matrix. Ann Plast Surg. 74(2):242–7 (2015 Feb).CrossRef B. R. DeGeorge Jr, M. C. Holland, D. B. Drake. The impact of conflict of interact in abdominal wall reconstruction with acellular dermal matrix. Ann Plast Surg. 74(2):242–7 (2015 Feb).CrossRef
15.
Zurück zum Zitat E. Swanson. Textured breast implants, anaplastic large-cell lymphoma, and conflict of interest. Plast Reconstr Surg. 139(2):558e-559e (2017 Feb). E. Swanson. Textured breast implants, anaplastic large-cell lymphoma, and conflict of interest. Plast Reconstr Surg. 139(2):558e-559e (2017 Feb).
16.
Zurück zum Zitat A. A. Jefferson, S. D. Pearson. Conflict of interest in Seminal Hepatitis C Virus and cholesterol management guidelines. JAMA Intern Med. 177(3):352–7 (2017 Mar 1).CrossRef A. A. Jefferson, S. D. Pearson. Conflict of interest in Seminal Hepatitis C Virus and cholesterol management guidelines. JAMA Intern Med. 177(3):352–7 (2017 Mar 1).CrossRef
17.
Zurück zum Zitat J. P. Ioannidis. Why most published research findings are false. PLoS Med. 2(8):e124 (2005 Aug).CrossRef J. P. Ioannidis. Why most published research findings are false. PLoS Med. 2(8):e124 (2005 Aug).CrossRef
20.
Zurück zum Zitat D. K. Flaherty DK. The vaccine-autism connection: A public health crisis caused by unethical medical practices and fraudulent science. Ann Pharmacother. 45(10):1302–1304 (2011 Oct). D. K. Flaherty DK. The vaccine-autism connection: A public health crisis caused by unethical medical practices and fraudulent science. Ann Pharmacother. 45(10):1302–1304 (2011 Oct).
21.
Zurück zum Zitat A. G. Dunn, D. Arachi, J. Hudgins, G. Tsafnat, E. Coiera, F. T. Bourgeois. Financial conflicts of interact and conclusions about neuraminidase inhibitors for influenza: An analysis of systematic reviews. Ann Intern Med. 161(7):513–8 (2014 Oct 7).CrossRef A. G. Dunn, D. Arachi, J. Hudgins, G. Tsafnat, E. Coiera, F. T. Bourgeois. Financial conflicts of interact and conclusions about neuraminidase inhibitors for influenza: An analysis of systematic reviews. Ann Intern Med. 161(7):513–8 (2014 Oct 7).CrossRef
Metadaten
Titel
The Effect of Financial Conflict of Interest, Disclosure Status, and Relevance on Medical Research from the United States
verfasst von
Deepa V. Cherla, MD
Cristina P. Viso, MD
Julie L. Holihan, MD, MS
Karla Bernardi, MD
Maya L. Moses, MD
Krislynn M. Mueck, MD
Oscar A. Olavarria, MD
Juan R. Flores-Gonzalez, MD
Courtney J. Balentine, MD
Tien C. Ko, MD
Sasha D. Adams, MD
Claudia Pedroza, PhD
Lillian S. Kao, MD, MS
Mike K. Liang, MD
Publikationsdatum
02.01.2019
Verlag
Springer International Publishing
Erschienen in
Journal of General Internal Medicine / Ausgabe 3/2019
Print ISSN: 0884-8734
Elektronische ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-018-4784-0

Weitere Artikel der Ausgabe 3/2019

Journal of General Internal Medicine 3/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.